Laxminarayan Bhat
CIK 1818245 · President and CEO · last filed 2026-03-20
Laxminarayan Bhat is a President and CEO who has filed 4 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing, for RVPH, was dated Mar 20, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVPH | President and CEO | — | $0.71 | — | $0 | 1 | 2026-03-20 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | President and CEO | — | $0.00 | — | $0 | 3 | 2025-02-18 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-20 | RVPH | Grant (A) | — | $0 | EDGAR |
| 2025-02-18 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-09-17 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-27 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |